Biotage Ab Stock Today
| BITGF Stock | USD 16.87 0.00 0.00% |
Performance9 of 100
| Odds Of DistressLess than 9
|
Biotage AB is trading at 16.87 as of the 18th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 16.87. Biotage AB has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Biotage AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of February 2024 and ending today, the 18th of April 2024. Click here to learn more.
Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States. The company has 65.98 M outstanding shares. More on Biotage AB
Moving together with Biotage OTC Stock
| 0.7 | GOOG | Alphabet Class C Earnings Call This Week | PairCorr |
| 0.62 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
Moving against Biotage OTC Stock
| 0.82 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.69 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.65 | INTC | Intel Earnings Call This Week | PairCorr |
| 0.59 | AAPL | Apple Inc Report 2nd of May 2024 | PairCorr |
| 0.45 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biotage OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biotage AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotage AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President and CEO | Torben Joergensen |
| Business Concentration | null, null, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Biotage AB [BITGF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotage AB's market, we take the total number of its shares issued and multiply it by Biotage AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotage AB classifies itself under null sector and is part of null industry. The entity has 65.98 M outstanding shares.
Biotage AB has accumulated about 15.1 M in cash with 353 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Biotage AB Probability Of Bankruptcy
Ownership AllocationBiotage AB holds a total of 65.98 Million outstanding shares. Over half of Biotage AB's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Biotage AB. Please watch out for any change in the institutional holdings of Biotage AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biotage Ownership Details
Biotage Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Biotage AB jumping above the current price in 90 days from now is under 4%. The Biotage AB probability density function shows the probability of Biotage AB otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Biotage AB has a beta of -0.2432 suggesting as returns on the benchmark increase, returns on holding Biotage AB are expected to decrease at a much lower rate. During a bear market, however, Biotage AB is likely to outperform the market. Additionally, biotage AB has an alpha of 0.616, implying that it can generate a 0.62 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Biotage AB to move above the current price in 90 days from now is under 4 (This Biotage AB probability density function shows the probability of Biotage OTC Stock to fall within a particular range of prices over 90 days) .
Biotage AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biotage AB market risk premium is the additional return an investor will receive from holding Biotage AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biotage AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biotage AB's alpha and beta are two of the key measurements used to evaluate Biotage AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.21 | |||
| Standard Deviation | 5.0 | |||
| Variance | 24.95 | |||
| Risk Adjusted Performance | 0.0863 |
Biotage Stock Against Markets
Picking the right benchmark for Biotage AB otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biotage AB otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biotage AB is critical whether you are bullish or bearish towards Biotage AB at a given time. Please also check how Biotage AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biotage AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Biotage AB Corporate Directors
Biotage AB corporate directors refer to members of a Biotage AB board of directors. The board of directors generally takes responsibility for the Biotage AB's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biotage AB's board members must vote for the resolution. The Biotage AB board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Karolina Lawitz | Member of the Board of Directors | Profile | |
| NilsOlof Bjork | Director | Profile | |
| Love Amcoff | Director, Employee Representative | Profile | |
| Thomas Eklund | Member of the Board of Directors | Profile |
How to buy Biotage OTC Stock?
Before investing in Biotage AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biotage AB. To buy Biotage AB stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biotage AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biotage AB stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biotage AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biotage AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biotage AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Biotage AB?
The danger of trading Biotage AB is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biotage AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biotage AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biotage AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |